Monashee Investment Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-55,000
| Closed | -$699K | – | 99 |
|
|
2024
Q3 | $699K | Buy |
55,000
+14,500
| +36% | +$184K | 0.08% | 103 |
|
|
2024
Q2 | $680K | Buy |
+40,500
| New | +$680K | 0.09% | 70 |
|
|
2017
Q4 | – | Hold |
0
| – | -$594K | – | 164 |
|
|
2017
Q3 | – | Sell |
-32,908
| Closed | -$594K | – | 69 |
|
|
2017
Q2 | $594K | Buy |
+32,908
| New | +$594K | 0.25% | 68 |
|